Optovite B12 (Cyanocobalamin)

Cyanocobalamin, the active ingredient in Optovite B12, is a vitamin B12 presented as a sterile injectable solution for intramuscular, intravenous, subcutaneous use. It treats vitamin B12 deficiency and related anemia in patients who require supplementation.

GNH USA supplies Optovite B12 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Optovite B12 (cyanocobalamin) is used to correct vitamin B12 deficiency and related hematologic disorders.

- Vitamin B12 deficiency: restores normal serum cobalamin levels and supports hematopoiesis. - Pernicious anemia: provides the required cobalamin for patients with intrinsic factor deficiency. - Megaloblastic anemia: corrects DNA synthesis defects and improves red cell maturation.

Adverse reactions may occur following administration of cyanocobalamin injections.

Common Side Effects: - Injection site pain or erythema: mild discomfort at the site of administration. - Headache: transient and usually resolves without intervention. - Nausea: mild gastrointestinal upset after injection.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Severe hypersensitivity: includes rash, swelling, and respiratory difficulty. - Thrombophlebitis: inflammation of a vein at the injection site that may lead to clot formation.

Cyanocobalamin should be used with attention to patient‑specific factors and handling requirements.

- Assess baseline cobalamin status: verify deficiency before initiating therapy. - Monitor for allergic reactions: observe patients after the first dose. - Use caution in renal impairment: adjust monitoring as needed. - Avoid in known hypersensitivity to cyanocobalamin or excipients. - Evaluate risk‑benefit in pregnancy: consider only if clearly needed. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Cyanocobalamin may interact with other medications that affect its absorption or activity.

Major Interactions (Avoid): - Metformin: long‑term use can reduce vitamin B12 absorption. - Proton pump inhibitors: chronic therapy may impair cobalamin uptake. - H2‑receptor antagonists: may diminish gastric acidity needed for absorption.

Moderate Interactions (Monitor Closely): - Tetracycline antibiotics: can alter gut flora influencing B12 synthesis. - Cholestyramine: may bind cobalamin and decrease its bioavailability. - Nitrous oxide anesthesia: inactivates vitamin B12 and can exacerbate deficiency.